Biological Effects of Inhaled Hydraulic Fracturing Sand Dust. VI. Cardiovascular Effects
Public Domain
-
2020/11/01
-
Details
-
Personal Author:Cumpston J ; Fedan, Jeffery S. ; Johnson C ; Kan H ; Kashon ML ; Krajnak, Kristine M. ; McKinney W ; Russ KA ; Waugh, Stacey ; Zheng W
-
Description:Hydraulic fracturing is used to access oil and natural gas reserves. This process involves the high-pressure injection of fluid to fracture shale. Fracking fluid contains approximately 95% water, chemicals and 4.5% fracking sand. Workers may be exposed to fracking sand dust (FSD) during the manipulation of the sand, and negative health consequences could occur if FSD is inhaled. In the absence of any information about its potential toxicity, a comprehensive rat animal model study (see Fedan et al., 2020) was designed to investigate the bioactivities of several FSDs in comparison to MIN-U-SIL 5, a respirable a-quartz reference dust used in previous animal models of silicosis, in several organ systems. The goal of this study was to assess the effects of inhalation of one FSD, i.e., FSD 8, on factors and tissues that affect cardiovascular function. Male rats were exposed to 10 or 30 mg/m3 FSD (6 h/d for 4 d) by whole body inhalation, with measurements made 1, 7 or 27 d post-exposure. One day following exposure to 10 mg/m3 FSD the sensitivity to phenylephrine-induced vasoconstriction in tail arteries in vitro was increased. FSD exposure at both doses resulted in decreases in heart rate (HR), HR variability, and blood pressure in vivo. FSD induced changes in hydrogen peroxide concentrations and transcript levels for pro-inflammatory factors in heart tissues. In kidney, expression of proteins indicative of injury and remodeling was reduced after FSD exposure. When analyzed using regression analysis, changes in proteins involved in repair and remodeling were correlated. Thus, it appears that inhalation of FSD does have some prolonged effects on cardiovascular, and, possibly, renal function. The findings also provide information regarding potential mechanisms that may lead to these changes, and biomarkers that could be examined to monitor physiological changes that could be indicative of impending cardiovascular dysfunction. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0041-008X
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:406
-
NIOSHTIC Number:nn:20061042
-
Citation:Toxicol Appl Pharmacol 2020 Nov; 406:115242
-
Contact Point Address:Kristine Krajnak, Engineering Controls and Technology Branch, National Institute for Occupational Safety and Health, 1000, Frederick Lane, Morgantown, WV 26508, United States of America
-
Email:ksk1@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2021
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Toxicology and Applied Pharmacology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:69045cbe266fcc4faaa65e021cbef73597a05ab27b057b8b3deb13c90ccbb0c7dfa6d0be950e3594d54eeaa03825d2227d0c153188ef4c98ea582f082f13131c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like